Madiro invests in pre-Seed to Series A healthcare opportunities that will improve health in Sub-Saharan Africa.

Our focus is on supporting potentially transformative innovation in global health and humanitarian service to attain widespread adoption. We provide patient capital of between USD 75k-1m and technical assistance to set high-impact, early-stage innovations on a strong trajectory toward scale. If you believe your company falls within our investment focus and could benefit from Madiro's support, please complete our Investment Intake Form.